List of Oncology Medication For

Leukemia

Tagraxofusp-erzs-Injection

tagraxofusp-erzs injection,
for intravenous use Initial U.S. Approval: 2018

Elzonris (tagraxofusp-erzs) is a medication used to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older.

Facts about tagraxofusp-erzs-injection

Disease Indications -Leukemia
Manufacturer-Stemline Therapeutics
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “tagraxofusp-erzs-injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

TIBSOVO (ivosidenib Tablets)

Leukemia, Bile Duct Cancer

Generic Name: ivosidenib Brand Name: TIBSOVO
TIBSOVO (ivosidenib tablets) is used to treat acute myeloid leukemia (AML).

TIBSOVO is a kinase inhibitor indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test. If you have any questions about your illness, talk to your doctor.

Brand Name:	TIBSOVO
Generic Name:	ivosidenib
Strength:	Tablets: 250 mg (3
Manufacturer:	Servier Pharmaceuticals
Approved By:	EMA, USFDA

Source Details: Patient Information

Access Patient Name Basis Treatment

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import TIBSOVO (ivosidenib Tablets) ” based on the information you provide.

VANFLYTA (quizartinib) Tablets

Leukemia

Brand Name: VANFLYTA. Generic Name: (quizartinib). VANFLYTA (quizartinib) is used to use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteria.

VANFLYTA is a kinase inhibitor (a kinase is a type of protein that regulates the function of cells in your body) that is used in combination with certain chemotherapy medicines and alone as maintenance therapy to treat adults with newly diagnosed acute myeloid leukemia (AML) with a specific mutation called FLT3 internal tandem duplication (FLT3-ITD) mutation. VANFLYTA is not indicated for use alone as maintenance therapy following a stem cell transplantation (bone marrow transplant).

Brand Name:	VANFLYTA
Generic Name:	quizartinib
Strength:	Tablets: 17.7 mg or 26.5 mg.
Manufacturer:	Daiichi Sankyo, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “VANFLYTA (quizartinib)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for VANFLYTA (quizartinib) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

VENCLEXTA (venetoclax) tablets

Blood Disorders, Leukemia, Lymphoma

VENCLEXTA (venetoclax) tablets, for oral use Initial U.S. Approval: 2016

VENCLEXTA is a prescription medicine used:

to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
in combination with azacitidine, or decitabine, or low-dose cytarabine to treat adults with newly diagnosed acute myeloid leukemia (AML)

Brand Name:	VENCLEXTA
Generic Name:	Venetoclax
Strength:	• Tablets: 10 mg, 50 mg, 100 mg
Manufacturer:	AbbVie Inc
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “VENCLEXTA (venetoclax) tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for VENCLEXTA (venetoclax) tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

VYXEOS (daunorubicin and cytarabine) liposome for Injection

Bone marrow, Leukemia, Uncategorized

VYXEOS (daunorubicin and cytarabine) liposome for injection, for intravenous use Initial U.S. Approval: 2017

VYXEOS is a liposomal combination of daunorubicin, an anthracycline topoisomerase inhibitor, and cytarabine, a nucleoside metabolic inhibitor, that is indicated for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).
Manufacturer: Jazz Pharmaceuticals, Inc.
Dosage, Form & Strength: VYXEOS is a sterile, preservative-free, purple, lyophilized cake for reconstitution supplied in a single-dose clear glass vial as follows: • For injection: 44 mg daunorubicin and100 mg cytarabine encapsulated in liposomes. If you have any questions about your illness, talk to your doctor
Source Details: Patient Information

Access Patient Name Basis Treatment

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import VYXEOS (daunorubicin and cytarabine) liposome” based on the information you provide.

VYXEOS (daunorubicin and cytarabine) liposome for injection

Leukemia, Blood Disorders

Brand Name: VYXEOS. Generic Name: (Daunorubicin/cytarabine). It is used to treat acute myeloid leukemia (t-AML) or AML.

VYXEOS is a liposomal combination of daunorubicin, an anthracycline topoisomerase inhibitor, and cytarabine, a nucleoside metabolic inhibitor, that is indicated for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).

Brand Name:	VYXEOS
Generic Name:	Daunorubicin/cytarabine
Strength:	• For injection: 44 mg daunorubicin and 100 mg cytarabine encapsulated in liposomes as a lyophilized cake in a single-dose vial for reconstitution
Manufacturer:	Jazz Pharmaceuticals, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “VYXEOS (daunorubicin and cytarabine) liposome for injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

XOSPATA (Gilteritinib) Tablets

Leukemia

Generic Name: Gilteritinib. Brand Name: XOSPATA.
XOSPATA (gilteritinib) tablets is used to treat acute myeloid leukemia (AML).

XOSPATA is a kinase inhibitor indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF).

Brand Name:	Xospata
Generic Name:	Gilteritinib
Strength:	Tablets: 40 mg
Manufacturer:	Astellas Pharma Inc.
Approved By:	EMA, USFDA, Health Canada, TGA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “XOSPATA (gilteritinib) Tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for XOSPATA (gilteritinib) Tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

ZOLINZA (vorinostat) Capsules

Leukemia

ZOLINZA (vorinostat) Capsules Initial U.S. Approval: 2006

ZOLINZA is a histone deacetylase (HDAC) inhibitor indicated for • Treatment of cutaneous manifestations in patients with cutaneous Tcell lymphoma (CTCL) who have progressive, persistent or recurrent disease on or following two systemic therapies.

Name: ZOLINZA
Generic Name : Vorinostat
Strength: Capsules 100mg
Manufactured: Merck & Co., Inc.

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import ZOLINZA-vorinostat” based on the information you provide.

ZYDELIG (idelalisib) Tablets

Leukemia, Lymphoma

ZYDELIG (idelalisib) tablets, for oral use. Initial U.S. Approval: 2014

Zydelig is a kinase inhibitor indicated for the treatment of patients with: • Relapsed chronic lymphocytic leukemia (CLL), in combination with rituximab, in patients for whom rituximab alone would be considered appropriate therapy due to other co-morbidities. • Relapsed follicular B-cell non-Hodgkin lymphoma (FL) in patients who have received at least two prior systemic therapies. • Relapsed small lymphocytic lymphoma (SLL) in patients who have received at least two prior systemic therapies.

Name: ZYDELIG
Generic Name : Idelalisib
Strength: 100mg Tablets.
Manufactured: Gilead Sciences, Inc.

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import ZYDELIG-idelalisib” based on the information you provide.

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Leukemia

Tagraxofusp-erzs-Injection

tagraxofusp-erzs injection,
for intravenous use Initial U.S. Approval: 2018

Access the best support services globally

TIBSOVO (ivosidenib Tablets)

Generic Name: ivosidenib Brand Name: TIBSOVO
TIBSOVO (ivosidenib tablets) is used to treat acute myeloid leukemia (AML).

Access Patient Name Basis Treatment

VANFLYTA (quizartinib) Tablets

Brand Name: VANFLYTA. Generic Name: (quizartinib). VANFLYTA (quizartinib) is used to use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteria.

VENCLEXTA (venetoclax) tablets

VENCLEXTA (venetoclax) tablets, for oral use Initial U.S. Approval: 2016

VYXEOS (daunorubicin and cytarabine) liposome for Injection

VYXEOS (daunorubicin and cytarabine) liposome for injection, for intravenous use Initial U.S. Approval: 2017

Access Patient Name Basis Treatment

VYXEOS (daunorubicin and cytarabine) liposome for injection

Brand Name: VYXEOS. Generic Name: (Daunorubicin/cytarabine). It is used to treat acute myeloid leukemia (t-AML) or AML.

XOSPATA (Gilteritinib) Tablets

Generic Name: Gilteritinib. Brand Name: XOSPATA.
XOSPATA (gilteritinib) tablets is used to treat acute myeloid leukemia (AML).

ZOLINZA (vorinostat) Capsules

ZOLINZA (vorinostat) Capsules Initial U.S. Approval: 2006

Access the best support services globally

ZYDELIG (idelalisib) Tablets

ZYDELIG (idelalisib) tablets, for oral use. Initial U.S. Approval: 2014

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

Company

Drugs Approved for

Gastroenterology

Hematology

Drugs Approved For

Leukemia

tagraxofusp-erzs injection, for intravenous use Initial U.S. Approval: 2018

Access the best support services globally

Generic Name: ivosidenib Brand Name: TIBSOVO TIBSOVO (ivosidenib tablets) is used to treat acute myeloid leukemia (AML).

Access Patient Name Basis Treatment

Brand Name: VANFLYTA. Generic Name: (quizartinib). VANFLYTA (quizartinib) is used to use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteria.

VENCLEXTA (venetoclax) tablets, for oral use Initial U.S. Approval: 2016

VYXEOS (daunorubicin and cytarabine) liposome for injection, for intravenous use Initial U.S. Approval: 2017

Access Patient Name Basis Treatment

Brand Name: VYXEOS. Generic Name: (Daunorubicin/cytarabine). It is used to treat acute myeloid leukemia (t-AML) or AML.

Generic Name: Gilteritinib. Brand Name: XOSPATA. XOSPATA (gilteritinib) tablets is used to treat acute myeloid leukemia (AML).

ZOLINZA (vorinostat) Capsules Initial U.S. Approval: 2006

Access the best support services globally

ZYDELIG (idelalisib) tablets, for oral use. Initial U.S. Approval: 2014

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

tagraxofusp-erzs injection,
for intravenous use Initial U.S. Approval: 2018

Generic Name: ivosidenib Brand Name: TIBSOVO
TIBSOVO (ivosidenib tablets) is used to treat acute myeloid leukemia (AML).

Generic Name: Gilteritinib. Brand Name: XOSPATA.
XOSPATA (gilteritinib) tablets is used to treat acute myeloid leukemia (AML).